Inventor · disambiguated record
Imadul Islam
Also filed as: ISLAM IMADUL
29 granted patents·11 pending applications·313 citations·filing 1992–2020
96Inventor score
Files withSCHERING AG16BRISTOL MYERS SQUIBB CO15SYNAPTIC PHARMA CORP3NAT GUARD HEALTH AFFAIRS2BAYER SCHERING PHARMA AG1
Top patents by PatentIndex Score
40 records- 0196US6391877B1Aryl sulfonamides and sulfamide derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted May 21, 2002·52 cites·39 claims
- 0294US6211241B1Aryl sulfonamides and sulfamide derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 1998·Granted Apr 3, 2001·58 cites·11 claims
- 0394US6207665B1Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 1998·Granted Mar 27, 2001·89 cites·11 claims
- 0490US6861424B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2002·Granted Mar 1, 2005·19 cites·60 claims
- 0589US9221796B2Selective NR2B antagonistsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 29, 2015·5 cites·12 claims
- 0689US6555537B2Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2000·Granted Apr 29, 2003·24 cites·3 claims
- 0788US6534509B1Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2000·Granted Mar 18, 2003·19 cites·4 claims
- 0882US7026323B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2004·Granted Apr 11, 2006·8 cites·7 claims
- 0977US10639382B2Method for treating leukemiaNAT GUARD HEALTH AFFAIRS·Filed 2017·Granted May 5, 2020·2 cites·12 claims
- 1076US5246955AAntineoplastic compounds and methods of using sameRES CORP TECHNOLOGIES INC·Filed 1992·Granted Sep 21, 1993·17 cites·9 claims
- 1174US7105563B2Indolinone derivatives and their use in treating disease-states such as cancerSCHERING AG·Filed 2004·Granted Sep 12, 2006·10 cites·15 claims
- 1273US8722670B2Selective NR2B antagonistsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted May 13, 2014·2 cites·13 claims
- 1373US2021121453A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1472US6541476B1Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2000·Granted Apr 1, 2003·3 cites·9 claims
- 1571US10344020B2Selective NR2B antagonistsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jul 9, 2019·1 cites·13 claims
- 1669US2020163949A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1769US2019314358A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 1868US10954225B2Selective NR2B antagonistsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 23, 2021·0 cites·4 claims
- 1968US2019117638A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 2067US6995156B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2004·Granted Feb 7, 2006·2 cites·20 claims
- 2166US2018250283A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 2265US2018000807A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2365US2018110766A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2464US10961229B2Selective NR2B antagonistsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 30, 2021·0 cites·12 claims
- 2564US2017258777A1Selective NR2B AntagonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2662US8008325B2Plasma carboxypeptidase B inhibitorsBAYER SCHERING PHARMA AG·Filed 2008·Granted Aug 30, 2011·0 cites·14 claims
- 2762US7528173B2Plasma carboxypeptidase B inhibitorsSCHERING AKTIENGESELLSHAFT·Filed 2003·Granted May 5, 2009·2 cites·16 claims
- 2860US7268140B2Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2005·Granted Sep 11, 2007·0 cites·11 claims
- 2960US7176207B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2006·Granted Feb 13, 2007·0 cites·3 claims
- 3059US2016081995A1Selective NR2B AntagonistsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3156US10501451B2Selective NR2B antagonistsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 10, 2019·0 cites·19 claims
- 3256US6977258B2Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2003·Granted Dec 20, 2005·0 cites·19 claims
- 3356US6972290B2Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2003·Granted Dec 6, 2005·0 cites·23 claims
- 3453US7084142B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2006·Granted Aug 1, 2006·0 cites·15 claims
- 3553US6573266B1Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2000·Granted Jun 3, 2003·0 cites·4 claims
- 3652US7056923B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2003·Granted Jun 6, 2006·0 cites·16 claims
- 3749US6734182B2Aryl sulfonamides and sulfamide derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2002·Granted May 11, 2004·0 cites·25 claims
- 3849US2011319366A1Plasma Carboxypeptidase B InhibitorsBUCKMAN BRAD·Filed 2011·Application pending·0 cites
- 3945US11161823B2Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereofNAT GUARD HEALTH AFFAIRS·Filed 2020·Granted Nov 2, 2021·0 cites·11 claims
- 4045US2004266755A1Prodrugs of 1-(1-hydroxy-5-isoquinolinesulfonyl) homopiperazineSCHERING AG·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Imadul Islam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →